The company a limited liability company incorporated in the PRC on June 11. The Company and its subsidiaries are principally engaged in operating its mainly provide (i) CRO services, namely peptide NCE discovery synthesis; and (ii) CDMO services, namely peptide CMC development and commercial manufacturing. The services primarily focus on providing customers with APIs rather than drug products.
Headquarters
No. 69, 12 Street, Qiantang District
Hangzhou; Zhejiang;
Contact Details: Purchase the Medtide Inc. (泰德医药（浙江）股份有限公司) report to view the information.
Website: http://medtideinc.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service